| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.7M | +37.6% |
| R&D Expense | $5.0M | -33.3% |
| SG&A Expense | $25.7M | -22.0% |
| Operating Income | -$31.0M | +40.6% |
| Pre-tax Income | -$4.1M | +96.4% |
| Income Tax | $673K | -76.5% |
| Net Income | -$4.8M | +95.9% |
| EPS (Basic) | -$0.04 | +96.9% |
| EPS (Diluted) | -$0.18 | +85.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $94.4M | +319.8% |
| Accounts Receivable | $8.5M | +483.9% |
| Inventory | $2.1M | — |
| Current Assets | $115.2M | +313.3% |
| Total Assets | $151.3M | +145.3% |
| Current Liabilities | $22.5M | -35.0% |
| Total Liabilities | $90.8M | -20.9% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.9M | +25.1% |
| Capital Expenditures | $7.4M | +46.4% |
| Investing Cash Flow | -$7.4M | -46.6% |
| Financing Cash Flow | $112.5M | +200.4% |
| Free Cash Flow | -$34.3M | +16.3% |
| $60.5M |
| +214.1% |